Today: 29 April 2026
Browse Category

ASX:NEC 26 January 2026 - 2 February 2026

Australia stock market sinks as ASX 200 hit by gold rout — what to watch before the RBA call

Australia stock market sinks as ASX 200 hit by gold rout — what to watch before the RBA call

Australian shares fell sharply Monday, with the S&P/ASX 200 down 1.02% to 8,778.6, its lowest close since January 12, as gold miners led declines. Spot gold slid 3.2% to $4,708 an ounce amid forced selling, while BHP dropped 2.3% and Santos lost 3.3%. The Aussie dollar slipped to $0.6924. Investors await Tuesday’s Reserve Bank of Australia rate decision.
2 February 2026
······
Australia stock market today: ASX 200 slips as miners sink, RBA rate call looms

Australia stock market today: ASX 200 slips as miners sink, RBA rate call looms

ASX 200 fell 0.65% to 8,869.1 as miners and gold stocks slumped, with Rio Tinto down 3.5% and BHP off 1.8%. Hotter-than-expected core inflation pushed markets to price in a 75% chance of an RBA rate hike next week. The Australian dollar slipped to 70.02 U.S. cents. Whitehaven reported a 21% jump in quarterly coal output to 11 million tonnes.
30 January 2026
·········
Australian dollar jumps to a 15-month high as rate-hike bets return

Australian dollar jumps to a 15-month high as rate-hike bets return

The Australian dollar hit $0.6917, its strongest since September 2024, as thin Australia Day holiday trading amplified volatility. A sharp drop in the U.S. dollar and record highs in gold and silver fueled the move. Traders now see a 63% chance of an RBA rate hike in February, with the cash rate steady at 3.60%. The ASX cash market was closed for the holiday.
26 January 2026

Stock Market Today

  • Ceres Power Surges Past Rolls-Royce, Nvidia, BP in FTSE 250 Rally
    April 29, 2026, 9:27 AM EDT. Ceres Power (LSE:CWR) leads the FTSE 250 stock gains in 2026 with a staggering 176% rise year-to-date, far outpacing Rolls-Royce, Nvidia and BP. The clean energy tech firm, specializing in licensing advanced solid oxide fuel cell and hydrogen technology, posted a remarkable 933% gain over the last year. Despite declining revenues - £32.6 million in 2025 down from £51.9 million the previous year - and no expected profits in 2026 or 2027, investor enthusiasm is fueled by the AI-driven data center boom. Its recent collaboration with Centrica aims to deploy efficient on-site power solutions swiftly for AI hubs and logistics centers. This positions Ceres as a crucial 'picks and shovels' provider amid the AI energy surge. However, over five years, the stock remains down 55%, prompting debate on its current valuation.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Go toTop